David A. Alagpulinsa, PhD

David is an Assistant Professor of Comparative and Cardiovascular Medicine. His doctoral studies in Interdisciplinary Biomedical Sciences at the University of Arkansas for Medical Scinces in Little Rock, Arkansas, focused on defining and exploiting the mechanisms that maintain genome integrity in multiple myeloma, a hematologic malignancy of B lymphocytes. He completed a postdoctoral training at the Massachusetts General Hospital and Harvard Medical School in Boston, developing strategies to immunoprotect endogenous and transplanted islets to treat type 1 diabetes without systemic immunosuppression. David joined the Yale Center for Molecular and Systems Metabolism and Department of Comparative Medicine at Yale as an Assistant Professor in 2023 to establish the AlagsLab. Research in the AlagsLab integrates knowledge from genetics, developmental and molecular biology, immunology, biomedical engineering, and statistical and computational biology to understand complex traits and diseases, including hematopoiesis, T1D, and cardiovascular disease.